Medi-Caps (BOM:523144) Cyclically Adjusted Revenue per Share: ₹42.09 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:523144 Medi-Caps Ltd BOM:523144
48 GF Score
Price ₹25.85
GF Value ₹21.10
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Medi-Caps Cyclically Adjusted Revenue per Share?

Medi-Caps BOM:523144 +2.87% 48 Cyclically Adjusted Revenue per Share is ₹42.09 as of Jun. 2026. GuruFocus rates BOM:523144 with a GF Score™ of 48/100 and a GF Value™ of ₹21.10 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medi-Caps's adjusted revenue per share for the three months ended in Jun. 2026 was ₹2.178. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹42.09 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medi-Caps's average Cyclically Adjusted Revenue Growth Rate was -4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-01), Medi-Caps's current stock price is ₹25.85. Medi-Caps's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹42.09. Medi-Caps's Cyclically Adjusted PS Ratio of today is 0.61.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medi-Caps was 1.18. The lowest was 0.52. And the median was 0.83.


Medi-Caps  (BOM:523144) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medi-Caps's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=25.85/42.09
=0.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medi-Caps was 1.18. The lowest was 0.52. And the median was 0.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medi-Caps Cyclically Adjusted Revenue per Share Related Terms


Medi-Caps Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medi-Caps's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medi-Caps Cyclically Adjusted Revenue per Share Chart

Medi-Caps Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 44.55 42.29

Medi-Caps Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.06 43.64 43.04 42.29 42.09

Medi-Caps Cyclically Adjusted Revenue per Share Competitor Comparison

For the Real Estate - Diversified subindustry, Medi-Caps's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medi-Caps Cyclically Adjusted PS Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Medi-Caps's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medi-Caps's Cyclically Adjusted PS Ratio falls into.


BOM:523144
48GF Score
Medi-Caps Ltd BOM:523144
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medi-Caps Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medi-Caps's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.178/167.3573*167.3573
=2.178

Current CPI (Jun. 2026) = 167.3573.

Medi-Caps Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 6.693 83.774 13.371
201303 7.079 85.687 13.826
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 6.324 111.317 9.508
201809 12.551 115.142 18.243
201812 10.677 115.142 15.519
201903 12.116 118.202 17.155
201906 12.654 120.880 17.519
201909 8.770 123.175 11.916
201912 6.759 126.235 8.961
202003 4.739 124.705 6.360
202006 13.243 127.000 17.451
202009 13.889 130.118 17.864
202012 14.567 130.889 18.626
202103 9.799 131.771 12.445
202106 13.751 134.084 17.163
202109 13.837 135.847 17.047
202112 13.855 138.161 16.783
202203 13.274 138.822 16.003
202206 9.925 142.347 11.669
202209 12.344 144.661 14.281
202212 8.746 145.763 10.042
202303 8.115 146.865 9.247
202306 4.980 150.280 5.546
202309 4.640 151.492 5.126
202312 5.482 152.924 5.999
202403 5.995 153.035 6.556
202406 4.969 155.789 5.338
202409 6.632 157.882 7.030
202412 3.215 158.323 3.398
202503 5.569 157.552 5.916
202506 2.146 159.755 2.248
202509 1.607 162.289 1.657
202512 3.419 163.281 3.504
202603 2.745 164.272 2.797
202606 2.178 167.357 2.178

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹42.09 mean?
Medi-Caps (BOM:523144) has a Cyclically Adjusted Revenue per Share of ₹42.09 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medi-Caps and its competitors.
Is Medi-Caps' Cyclically Adjusted Revenue per Share too high?
Medi-Caps' current Cyclically Adjusted Revenue per Share is ₹42.09. Overall, Medi-Caps has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medi-Caps' Cyclically Adjusted Revenue per Share compare to competitors?
Medi-Caps' Cyclically Adjusted Revenue per Share of ₹42.09 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Real Estate company?
A good Cyclically Adjusted Revenue per Share depends on the Real Estate industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medi-Caps and its competitors. Medi-Caps's current Cyclically Adjusted Revenue per Share is ₹42.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi-Caps stock overvalued right now?
Based on GuruFocus' analysis, Medi-Caps (BOM:523144) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹21.10, compared to a current price of ₹25.85 — trading 22.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹42.09. Medi-Caps' overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medi-Caps (BOM:523144), the current Cyclically Adjusted Revenue per Share is ₹42.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medi-Caps (BOM:523144) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹25.85 is trading 22.5% above its estimated GF Value™ of ₹21.10. GuruFocus considers Medi-Caps to be Modestly Overvalued.

Key valuation signals for BOM:523144:

  • Cyclically Adjusted Revenue per Share: ₹42.09
  • GF Value™: ₹21.10 vs. price of ₹25.85 (22.5% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the BOM:523144 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medi-Caps Business Description

Other Exchanges MEDICAPQ:India
Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
48GF Score

Get the complete analysis for BOM:523144

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.85
Price
₹21.10
GF Value